Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 41.86%871.75M | 56.48%257.88M | 51.93%231.57M | 32.55%197.42M | 24.64%184.88M | 23.64%614.49M | 24.68%164.8M | 18.94%152.42M | 24.15%148.94M | 27.10%148.33M |
Operating revenue | 42.06%861.74M | 57.39%256.59M | 52.04%228.83M | 31.97%193.56M | 24.84%182.75M | 23.70%606.6M | 24.90%163.03M | 19.09%150.5M | 23.77%146.68M | 27.34%146.39M |
Cost of revenue | 46.61%633.58M | 66.38%191.85M | 61.98%170.91M | 34.53%138.67M | 22.08%132.15M | 24.42%432.15M | 26.66%115.31M | 16.85%105.51M | 22.51%103.08M | 32.25%108.25M |
Gross profit | 30.62%238.17M | 33.41%66.03M | 29.32%60.67M | 28.10%58.75M | 31.56%52.73M | 21.82%182.34M | 20.30%49.49M | 23.91%46.91M | 28.01%45.86M | 14.99%40.08M |
Operating expense | 17.70%193.31M | 28.47%51.84M | 16.77%48.58M | 17.65%48.52M | 8.09%44.38M | 7.60%164.25M | 1.89%40.35M | 7.29%41.6M | 8.36%41.24M | 13.35%41.06M |
Selling and administrative expenses | 18.31%141.98M | 28.89%38.28M | 15.79%35.39M | 18.63%35.98M | 9.94%32.33M | 7.69%120M | 1.34%29.7M | 7.53%30.56M | 8.83%30.33M | 13.83%29.41M |
-Selling and marketing expense | 25.07%105.05M | 38.47%28.6M | 23.14%26.45M | 23.92%26.77M | 14.68%23.24M | 14.60%84M | 2.21%20.65M | 12.77%21.48M | 21.00%21.6M | 25.16%20.26M |
-General and administrative expense | 2.56%36.93M | 7.02%9.68M | -1.59%8.94M | 5.54%9.21M | -0.58%9.09M | -5.60%36.01M | -0.59%9.05M | -3.13%9.08M | -12.85%8.73M | -5.18%9.15M |
Research and development costs | 16.01%51.33M | 27.30%13.56M | 19.50%13.19M | 14.93%12.54M | 3.42%12.05M | 7.35%44.25M | 3.48%10.65M | 6.62%11.04M | 7.09%10.91M | 12.16%11.65M |
Operating profit | 147.92%44.86M | 55.25%14.19M | 127.60%12.09M | 121.27%10.24M | 947.87%8.34M | 707.96%18.09M | 494.66%9.14M | 679.17%5.31M | 307.91%4.63M | 28.23%-984K |
Net non-operating interest income expense | 24.55%8.74M | 0.20%2.02M | 22.94%2.34M | 32.33%2.19M | 51.81%2.19M | 322.07%7.02M | 88.59%2.02M | 277.98%1.91M | 1,591.84%1.66M | 18,100.00%1.44M |
Non-operating interest income | 24.55%8.74M | 0.20%2.02M | 22.94%2.34M | 32.33%2.19M | ---- | 322.07%7.02M | --2.02M | --1.91M | --1.66M | ---- |
Total other finance cost | ---- | ---- | ---- | ---- | -51.81%-2.19M | ---- | ---- | ---- | ---- | -18,100.00%-1.44M |
Other net income (expense) | 2,775.00%345K | 59.09%70K | 129.41%5K | 657.14%39K | 2,987.50%231K | 140.00%12K | 193.62%44K | 39.29%-17K | -112.96%-7K | -130.77%-8K |
Gain on sale of security | ---- | ---- | ---- | ---- | 325.00%18K | ---- | ---- | ---- | ---- | -130.77%-8K |
Other non- operating income (expenses) | 2,775.00%345K | 59.09%70K | 129.41%5K | 657.14%39K | --213K | 140.00%12K | --44K | ---17K | ---7K | ---- |
Income before tax | 114.71%53.94M | 45.36%16.28M | 100.51%14.44M | 98.65%12.47M | 2,301.79%10.76M | 2,020.80%25.12M | 337.67%11.2M | 1,732.43%7.2M | 402.80%6.28M | 133.11%448K |
Income tax | 248.86%9.78M | 74.14%3.13M | -99.39%5K | 608.90%3.11M | 1,480.47%3.53M | 452.45%2.8M | 12.23%1.8M | 177.70%822K | 15.87%438K | 91.66%-256K |
Net income | 97.87%44.17M | 39.85%13.15M | 126.28%14.43M | 60.37%9.36M | 926.42%7.23M | 4,451.27%22.32M | 882.45%9.4M | 965.26%6.38M | 338.23%5.84M | -59.02%704K |
Net income continuous Operations | 97.87%44.17M | 39.85%13.15M | 126.28%14.43M | 60.37%9.36M | 926.42%7.23M | 4,451.27%22.32M | 882.45%9.4M | 965.26%6.38M | 338.23%5.84M | -59.02%704K |
Minority interest income | ||||||||||
Net income attributable to the parent company | 97.87%44.17M | 39.85%13.15M | 126.28%14.43M | 60.37%9.36M | 926.42%7.23M | 4,451.27%22.32M | 882.45%9.4M | 965.26%6.38M | 338.23%5.84M | -59.02%704K |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 97.87%44.17M | 39.85%13.15M | 126.28%14.43M | 60.37%9.36M | 926.42%7.23M | 4,451.27%22.32M | 882.45%9.4M | 965.26%6.38M | 338.23%5.84M | -59.02%704K |
Basic earnings per share | 100.00%0.36 | 37.50%0.11 | 140.00%0.12 | 60.00%0.08 | 500.00%0.06 | 0.18 | 700.00%0.08 | 600.00%0.05 | 350.00%0.05 | 0.00%0.01 |
Diluted earnings per share | 94.44%0.35 | 25.00%0.1 | 120.00%0.11 | 40.00%0.07 | 500.00%0.06 | 0.18 | 700.00%0.08 | 600.00%0.05 | 350.00%0.05 | 0.00%0.01 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |